ZYLOX-TONBRDG.MED.TECH.H1 Working Capital to Net Assets Ratio
ZYLOX-TONBRDG.MED.TECH.H1 working capital to net assets ratio. ZYLOX-TONBRDG.MED.TECH.H1 (818) has a Working Capital to Net Assets ratio of 48.8% as of June 2025. Working capital of €1.54 Billion (current assets of €1.86 Billion minus current liabilities of €323.03 Million) is measured against net assets of €3.15 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ZYLOX-TONBRDG.MED.TECH.H1 (818) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of ZYLOX-TONBRDG.MED.TECH.H1 (2021–2024)
Working capital to net assets ratio of ZYLOX-TONBRDG.MED.TECH.H1 from 2021 to 2024. This chart shows how ZYLOX-TONBRDG.MED.TECH.H1's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 48.8%, reflecting working capital of €1.54 Billion against net assets of €3.15 Billion EUR. See 818 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
ZYLOX-TONBRDG.MED.TECH.H1 Working Capital to Net Assets Ratio by Year (2021–2024)
ZYLOX-TONBRDG.MED.TECH.H1 working capital to net assets ratio by year from 2021 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for ZYLOX-TONBRDG.MED.TECH.H1 from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ZYLOX-TONBRDG.MED.TECH.H1 assets under control.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 38.5% | €1.19 Billion | €3.10 Billion | €1.53 Billion | €334.17 Million | ▼ -7.4 pp |
| 2023 | 45.9% | €1.40 Billion | €3.05 Billion | €1.72 Billion | €317.78 Million | ▼ -15.8 pp |
| 2022 | 61.7% | €1.91 Billion | €3.09 Billion | €2.06 Billion | €152.08 Million | ▼ -31.3 pp |
| 2021 | 93.1% | €2.93 Billion | €3.14 Billion | €3.02 Billion | €97.10 Million | — |